Korean Market
OWNR
Daehan Nupharm
★

Daehan Nupharm major shareholder side I Won-seok buys 50,000 shares in open market... stake rises to 40.85%, signaling management stability

 
OWNR
Daehan Nupharm
★

CEO Won-seok Lee Increases Stake from 8.21% to 8.27% via Open Market Purchase... Insider Buying Signals Perceived Undervaluation

 
OWNR
Daehan Nupharm
★

CEO Won-seok Lee Increases Stake to 8.21% via Open Market Purchases... Seen as Positive Signal for Shareholder Value

 
OWNR
Daehan Nupharm
★

Filing of Large Shareholding Report (No Specific Information)

 
PERI
Daehan Nupharm
★

Daehan Nupharm Q1 2026: Revenue and Net Profit Up, Comprehensive Loss Due to Investment Valuation